Correlation Between Pliant Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Pliant Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Puma Biotechnology.
Diversification Opportunities for Pliant Therapeutics and Puma Biotechnology
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pliant and Puma is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 0.62 times more return on investment than Puma Biotechnology. However, Pliant Therapeutics is 1.6 times less risky than Puma Biotechnology. It trades about 0.05 of its potential returns per unit of risk. Puma Biotechnology is currently generating about -0.01 per unit of risk. If you would invest 1,382 in Pliant Therapeutics on September 13, 2024 and sell it today you would earn a total of 38.00 from holding Pliant Therapeutics or generate 2.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Puma Biotechnology
Performance |
| Timeline |
| Pliant Therapeutics |
| Puma Biotechnology |
Pliant Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Pliant Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Pliant Therapeutics vs. Puma Biotechnology | Pliant Therapeutics vs. Iovance Biotherapeutics | Pliant Therapeutics vs. Sarepta Therapeutics | Pliant Therapeutics vs. Day One Biopharmaceuticals |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |